Abstract

Chlamydia trachomatis (Ct) is the most common cause of bacterial sexually transmitted infection and infectious cause of blindness (trachoma) worldwide. Understanding the spatial distribution of Ct infection may enable us to identify populations at risk and improve our understanding of Ct transmission. In this study, we sought to investigate the spatial distribution of Ct infection and the clinical features associated with high Ct load in trachoma-endemic communities on the Bijagós Archipelago (Guinea Bissau). We collected 1507 conjunctival samples and corresponding detailed clinical data during a cross-sectional population-based geospatially representative trachoma survey. We used droplet digital PCR to estimate Ct load on conjunctival swabs. Geostatistical tools were used to investigate clustering of ocular Ct infections. Spatial clusters (independent of age and gender) of individuals with high Ct loads were identified using local indicators of spatial association. We did not detect clustering of individuals with low load infections. These data suggest that infections with high bacterial load may be important in Ct transmission. These geospatial tools may be useful in the study of ocular Ct transmission dynamics and as part of trachoma surveillance post-treatment, to identify clusters of infection and thresholds of Ct load that may be important foci of re-emergent infection in communities.

INTRODUCTION

Chlamydia trachomatis is the leading infectious cause of blindness and the most common sexually transmitted bacterium. Trachoma is caused by infection with ocular strains of C. trachomatis and manifests as distinct clinical syndromes, beginning with an acute self-limiting keratoconjunctivitis which may progress to chronic inflammatory disease with subsequent conjunctival scarring and blinding sequelae. A spectrum of disease severity exists, which can be graded objectively (Dawson, Jones and Tarizzo 1981; Thylefors et al. 1987).

The World Health Organization (WHO) advocates the implementation of the SAFE strategy (Surgery for trichiasis, Antibiotics for active infection, Facial cleanliness to prevent disease transmission and Environmental improvement to increase access to water and sanitation) for trachoma elimination. Mass Drug Administration (MDA) of azithromycin aims to clear infection from communities such that trachoma ceases to be a public health concern (Kuper et al. 2003).

Understanding the spatial distribution of disease and infection in trachoma-endemic regions is increasingly recognised in national trachoma control programme planning, enabling the identification of at-risk populations and prioritisation of target areas for control and implementation and optimal scaling of SAFE (Baker et al. 2010; Clements et al. 2010; Smith et al. 2011, 2013a,b). It may also be important in understanding transmission, transmission thresholds and the dynamics of spread and recovery from infection following intervention.

Spatial analysis provides powerful methods to study the relationship between active trachoma and ocular infection with C. trachomatis. The spatial relationship between disease and infection defined over space is termed spatial dependence. This is measured as the existence of statistical association (dependence) between disease and infection associated with location. To explore spatial dependence, measures of spatial autocorrelation are used. Spatial autocorrelation assumes that near objects are more related than distant objects. In the context of infectious diseases, this concept may be applied to explore the relationship between infection and disease where the spatial distribution can be used to define underlying processes such as exposure or transmission. Spatial regression models can thus be used to understand the epidemiology of active trachoma and C. trachomatis infection.

Global spatial autocorrelation statistics are used to describe the overall spatial patterns in the data. Local indicators of spatial association take actual values of observations in the context of adjacent values allowing mapping and definition of clusters at exact locations. This allows for the examination of small-scale heterogeneity and identification of statistically significant clusters and outliers of similar observations in space. In the context of global spatial patterns described above, this provides us with a greater understanding of the relationship between infection and disease.

In this study, we applied molecular and geostatistical tools to investigate the spatial epidemiology of C. trachomatis infection and active trachoma in a population-based study conducted in a trachoma-hyperendemic treatment-naïve population from the Bijagós Archipelago of Guinea Bissau in West Africa. This is the first study to use local indicators of spatial association using individual-level C. trachomatis load data in the context of spatial dependence to investigate the relationship between infection and disease. This is important in understanding the epidemiology of ocular C. trachomatis infection and may inform further studies on C. trachomatis transmission dynamics, which are fundamental to successful trachoma elimination and surveillance strategies.

MATERIALS AND METHODS

Ethical approval

This study was conducted in accordance with the declaration of Helsinki. Ethical approval was obtained from the Comitê Nacional de Ética e Saúde (Guinea Bissau), the LSHTM Ethics Committee (UK) and The Gambia Government/MRC Joint Ethics Committee (The Gambia). Written informed consent was obtained from all study participants or their guardians on their behalf if they were children. A signature or thumbprint is considered an appropriate record of consent in this setting by the above ethical bodies. After survey completion, all communities on the study islands were treated with a single height-based dose of oral azithromycin in accordance with WHO and national protocols.

Study area

The Bijagós Archipelago has a total area of more than 10 000 km2 and lies between N 11038΄19.68″ and N 10051΄40.32″, W 16029΄38.40″ and W 15027΄17.28″. The surface area covers ∼900 km2, of which 350 km2 is mangrove forest (Van der Linde and Dankin 1998). Maximum altitude is 50 m. The climate is humid and tropical, with a rainy season from May to November, when average monthly rainfall is 400 mm3 (World Bank 2013). Mean monthly temperature is 27.3°C (25.1°C–29.2°C), with peak temperatures prior to the rainy season. There are 88 islands and islets of which ∼20 are permanently inhabited. The remainder are inhabited periodically for seasonal agriculture and traditional initiation ceremonies. The study was conducted on four islands of the archipelago (Fig. 1). These four islands comprise a total rural population of 5613 (National Population Census, 2010, Instituto Nacional de Estatística, Guiné-Bissau) and a total area of 215 km2.

The Bijagós Archipelago, Guinea Bissau (© Ezilon 2009). The islands of Bubaque, Canhabaque, Rubane and Soga (circled in red) were included in the current study.
Figure 1.

The Bijagós Archipelago, Guinea Bissau (© Ezilon 2009). The islands of Bubaque, Canhabaque, Rubane and Soga (circled in red) were included in the current study.

Study design and study population

Trachoma survey methodology and this study population have been described previously (Edwards et al. 2008; Harding-Esch et al. 2010; Roberts et al. 2013; Last et al. 2014a,b). To satisfy adequate geospatial representation at village level, we included all 38 villages on the four study islands and randomly sampled one in five households (with a minimum of five per village) from each. All were sampled if there were fewer than six households in the village. Small villages are thus over-represented by the minimum sampling criteria imposed. Data were geocoded at household and village level using the Garmin eTrex H handheld Global Positioning Systems (GPS) unit (Garmin Ltd, UK).

Clinical examination and conjunctival sampling

A single validated examiner assessed each participant using the WHO simplified and modified FPC grading systems (Dawson, Jones and Tarizzo 1981; Thylefors et al. 1987). In the modified FPC system, follicles (F), papillae (P) and conjunctival scarring (C) are each assigned a separate grade from 0 to 3. FPC grades of F2/3 or P3 equate to a diagnosis of active trachoma (TF (follicular trachoma) or TI (inflammatory trachoma) by the WHO simplified system) and a grade of C2/3 (and in some cases C1) equates to a diagnosis of TS (trachomatous scarring). A trachoma grade was assigned to the upper tarsal conjunctivae of each consenting participant using adequate light and a ×2.5 binocular magnifying loupe. Both methods were used in order that study data should be comparable to data used by trachoma control programmes and research studies requiring detailed information related to disease severity and have been used previously in similar settings (Burton et al. 2003, 2006).

Samples were taken from the left upper tarsal conjunctiva of each participant with Dacron swabs (Fisher Scientific, UK) using a well-tolerated standardised procedure described in previous studies (Keenan et al. 2010; Stare et al. 2011; Roberts et al. 2013; Last et al. 2014a,b).

Detection and quantitation of Chlamydia trachomatis ocular infection

DNA extraction and droplet digital PCR (ddPCR) (Bio-Rad Laboratories, Hemel Hempstead, UK) were conducted as described previously (Roberts et al. 2013; Last et al. 2014a,b). We used C. trachomatis plasmid-based ddPCR to diagnose infection and a single-copy pathogen chromosomal gene (omcB) to estimate pathogen load in each plasmid-positive sample (Roberts et al. 2013; Last et al. 2014). The plasmid-based screening PCR included primers for human DNA (RPP30). A sample was deemed adequate if sufficient quantities of RPP30 DNA were present on PCR as defined previously (Roberts et al. 2013; Last et al. 2014).

Estimated quantities of omcB (C. trachomatis load) and plasmid are expressed as copies/swab. This is a method that we have previously employed for similar analyses (Solomon et al. 2003; Burton et al. 2003; Faal et al. 2006; Andreasen et al. 2008; Last et al. 2014; West et al. 2014). Data reported by Solomon et al. (2004) (showing a clear reduction in C. trachomatis load and disease severity in a trachoma-endemic community in Tanzania following mass drug treatment with azithromycin (MDA)), and Alexander et al. (2005) (showing a reduction in community C. trachomatis load (calculated using the same method) following MDA), provide evidence that measuring C. trachomatis load as copies/swab in this context is appropriate. We do not report C. trachomatis load per eukaryotic cell since inflammatory cells are attracted to the conjunctiva in the presence of ocular C. trachomatis infection which would be included amongst sampled cells and may artefactually decrease the C. trachomatis load. This is of particular concern in active trachoma, where inflammation can be intense and result in high loads of human cellular material on a swab. This phenomenon has also been noted in urogenital C. trachomatis infection (Jalal et al. 2011).

Statistical analysis

Chlamydia trachomatis quantitation data were processed as described previously (Roberts et al. 2013; Last et al. 2014). GPS data were downloaded into MapSource v16.16.3 (Garmin Ltd). All data were double entered into a customised database (Microsoft Access 2007) and discrepancies resolved through reference to source documents. Data were cleaned and analysed in STATA 13 (Stata Corporation, College Station, TX, USA). Statistical significance was determined at the 5% level.

Mixed effects linear regression models of Chlamydia trachomatis load and clinical phenotype

Chlamydia trachomatis load data were log(e) transformed where indicated. The geometric mean of load, respective standard error (SE) and 95% confidence intervals (CI) were calculated. An analysis of variance (ANOVA) with pairwise comparisons was used to compare load across detailed clinical phenotypes. Assessment of group differences and multiple comparisons were adjusted for using the Scheffé correction (Ruxton and Beauchamp 2008). Associations between load and detailed clinical phenotype were examined using univariable and multivariable mixed effects linear and logistic regression models accounting for household-level clustering detected in previous studies (Last et al. 2014).

Geostatistical analyses

Geocoded data were projected into UTM Zone 28N. ArcGIS 10.1 (ESRI Inc., USA) and the R statistical package v3.0.2 (The R Foundation for Statistical Computing, http://www.r-project.org using spdep, automap and nlme packages) were used for all geostatistical analyses (Bivand 2010; Hiemstra et al. 2009; Pinheiro et al. 2014). In the following analyses, the zone of indifference is used to define adjacency. This method assumes that each observation has local influence that decreases with distance beyond a critical distance cut-off, resulting in an adapted model of impedance, or distance decay, such that all features have an impact on all other features, but this impact decreases with distance. The crucial cut-off used in this study is derived from the distance over which spatial autocorrelation occurs in these data and relates to the village boundaries, assuming impedance as described above. Previously we have shown that clustering exists at this level in these communities (Last et al. 2014), which supports using this threshold. This method is appropriate for point data and takes into account the extent of spatial autocorrelation in selecting data-driven threshold cut-offs (Chang 2010).

Spatial autocorrelation

The Moran's I statistic was used to evaluate global spatial autocorrelation in the distribution of the household-level prevalence of disease and infection. The values of Moran's I range between –1 and +1. A value close to –1 indicates negative autocorrelation (complete dispersion), while a value close to +1 indicates positive autocorrelation (clustering) of features. A value close to 0 suggests random arrangement. Z-scores and P-values are assigned to ascertain whether spatial autocorrelation is statistically significant (Moran 1950). Since the Moran's I statistic can be sensitive to skewed distributions, a permutation test was used to verify the results. This uses Monte Carlo simulations to generate a Moran's I sampling distribution (Cliff and Ord 1981).

Empirical semivariograms were used to obtain the distance range over which spatial autocorrelation occurs using the average squared distance between paired data values against the distance (or lag) separating the pairs to estimate the spatial covariance structure of the data to inform the geostatistical models (Diggle, Tawn and Moyeed 1998).

Linear and logistic mixed effects regression models were also applied to examine the effect of spatial autocorrelation on clustering. We used the covariance structure to compare models with and without a spatial component. The log likelihood, Akaike information criterion (AIC) and Bayesian information criterion (BIC) were used to compare models (Zucchini 2000).

Local indicators of spatial association: cluster–outlier analyses

Clustering and outlier analysis was applied using the local (Anselin) Moran's I statistic in ArcGIS 10.1 Spatial Statistics Toolbox (ESRI Inc., USA). The zone of indifference was used to define adjacency and the Euclidean distance threshold was derived from empirical semivariograms as described above. The Euclidean distance threshold was thus the distance over which the highest positive spatial autocorrelation for C. trachomatis infection existed. Together, these account for the geography (islands with populated (villages) and non-populated areas) (Anselin 1995). Individuals’ C. trachomatis loads were used as the variable of interest. Since these populations and areas are small with little ecological variation, this single threshold value is sufficient. A positive value for I indicates that a feature has adjacent features with similarly high or low attributable values (a cluster). A negative value for I indicates that adjacent features have dissimilar values and that this feature is an outlier. Cluster–outlier analysis identifies spatial clusters of features with high or low values and spatial outliers by calculating Moran's I, Z-scores, P-values and a code to represent the cluster type. Cluster types are defined as clusters of high values (HH, high-high), clusters of low values (defined as above) (LL, low-low), a high value outlier surrounded by predominantly low values (HL, high-low) and a low value outlier surrounded by predominantly high values (LH, low-high). A group of geospatially proximal infections where the bacterial load values are not statistically similar is defined as a non-significant cluster.

In this analysis, ‘low’ values include both low values related to low load infections and null (zero) values related to uninfected individuals. To explore this, these analyses were conducted first on the whole data set, including uninfected individuals with a ‘zero’ value for infectious load, and then on infected individuals only.

RESULTS

Trachoma and Chlamydia trachomatis infection prevalence is hyperendemic in this population and is described elsewhere in detail (Roberts et al. 2013; Last et al. 2014). All swab samples in the study were positive for the presence of the human DNA target RPP30. Chlamydia trachomatis load was skewed, with the majority of cases having low copy numbers (<1000 copies/swab). Log-(e) transformation removed the skew (skewness –0.106, P = 0.5454) in these analyses.

Chlamydia trachomatis bacterial load and clinical disease severity in individuals with Chlamydia trachomatis infection

The geometric mean of estimated omcB copies/swab present in clinically normal conjunctivae (F0/P0/C0) was 294 copies/swab (95% C.I. 165–524). In clinically active trachoma, it was 8562 copies/swab (95% C.I. 5412–13546). Significantly higher loads were detected in individuals with increasing F and P scores (Table 1). Chlamydia trachomatis load by age and clinical phenotype is shown in Fig. 2. The majority of infections with high loads were in children under 10 years of age with active trachoma.

Chlamydia trachomatis load by age and clinical phenotype in infected individuals. The y axis shows the natural logarithmic scale of C. trachomatis bacterial load (omcB copies/swab).
Figure 2.

Chlamydia trachomatis load by age and clinical phenotype in infected individuals. The y axis shows the natural logarithmic scale of C. trachomatis bacterial load (omcB copies/swab).

Table 1.

Estimated C. trachomatis load (omcB copies/swab) and ANOVAa by detailed clinical phenotype in infected individuals.

ClinicalomcB copies/swab95% CIP-Value
phenotypenb(geometric mean)(SE geometric mean)(ANOVA)MedianMinMax
Normal (F0P0C0)71294165, 524Baseline1761596333
Active trachoma (TF and/or TI)9285625412, 13546P <0.000011423617274835
Scarring trachoma (TS)19928280, 3074P = 0.406921421749125
Follicular score (F)
 091438251, 762Baseline22715202632
 1201288448, 3697P = 0.324Baseline17103496333
 22732121264, 8165P =0.002P = 0.624Baseline320327140693
 346198702832, 25927P < 0.0001P < 0.0001P = 0.01822767323274835
Inflammatory score (P)
 04612268, 218Baseline671541059
 1701534871, 2702P <0.0001Baseline146916202632
 246104135461, 19857P <0.0001P <0.0001Baseline1856917274835
 322140535550, 35581P <0.0001P <0.0001P = 0.9642186434158548
Scarring score (C)
 015519021207, 2996Baseline209515274835
 111449111, 1816P = 0.438Baseline2043411556
 29990192, 5111P = 0.927P = 0.941Baseline5897654651
 392475253, 24192P = 0.995P = 0.608P = 0.92370231749125
ClinicalomcB copies/swab95% CIP-Value
phenotypenb(geometric mean)(SE geometric mean)(ANOVA)MedianMinMax
Normal (F0P0C0)71294165, 524Baseline1761596333
Active trachoma (TF and/or TI)9285625412, 13546P <0.000011423617274835
Scarring trachoma (TS)19928280, 3074P = 0.406921421749125
Follicular score (F)
 091438251, 762Baseline22715202632
 1201288448, 3697P = 0.324Baseline17103496333
 22732121264, 8165P =0.002P = 0.624Baseline320327140693
 346198702832, 25927P < 0.0001P < 0.0001P = 0.01822767323274835
Inflammatory score (P)
 04612268, 218Baseline671541059
 1701534871, 2702P <0.0001Baseline146916202632
 246104135461, 19857P <0.0001P <0.0001Baseline1856917274835
 322140535550, 35581P <0.0001P <0.0001P = 0.9642186434158548
Scarring score (C)
 015519021207, 2996Baseline209515274835
 111449111, 1816P = 0.438Baseline2043411556
 29990192, 5111P = 0.927P = 0.941Baseline5897654651
 392475253, 24192P = 0.995P = 0.608P = 0.92370231749125
a

Scheffé correction used for multiple comparisons.

b

n = number of individuals with quantifiable C. trachomatis bacterial load.

Table 1.

Estimated C. trachomatis load (omcB copies/swab) and ANOVAa by detailed clinical phenotype in infected individuals.

ClinicalomcB copies/swab95% CIP-Value
phenotypenb(geometric mean)(SE geometric mean)(ANOVA)MedianMinMax
Normal (F0P0C0)71294165, 524Baseline1761596333
Active trachoma (TF and/or TI)9285625412, 13546P <0.000011423617274835
Scarring trachoma (TS)19928280, 3074P = 0.406921421749125
Follicular score (F)
 091438251, 762Baseline22715202632
 1201288448, 3697P = 0.324Baseline17103496333
 22732121264, 8165P =0.002P = 0.624Baseline320327140693
 346198702832, 25927P < 0.0001P < 0.0001P = 0.01822767323274835
Inflammatory score (P)
 04612268, 218Baseline671541059
 1701534871, 2702P <0.0001Baseline146916202632
 246104135461, 19857P <0.0001P <0.0001Baseline1856917274835
 322140535550, 35581P <0.0001P <0.0001P = 0.9642186434158548
Scarring score (C)
 015519021207, 2996Baseline209515274835
 111449111, 1816P = 0.438Baseline2043411556
 29990192, 5111P = 0.927P = 0.941Baseline5897654651
 392475253, 24192P = 0.995P = 0.608P = 0.92370231749125
ClinicalomcB copies/swab95% CIP-Value
phenotypenb(geometric mean)(SE geometric mean)(ANOVA)MedianMinMax
Normal (F0P0C0)71294165, 524Baseline1761596333
Active trachoma (TF and/or TI)9285625412, 13546P <0.000011423617274835
Scarring trachoma (TS)19928280, 3074P = 0.406921421749125
Follicular score (F)
 091438251, 762Baseline22715202632
 1201288448, 3697P = 0.324Baseline17103496333
 22732121264, 8165P =0.002P = 0.624Baseline320327140693
 346198702832, 25927P < 0.0001P < 0.0001P = 0.01822767323274835
Inflammatory score (P)
 04612268, 218Baseline671541059
 1701534871, 2702P <0.0001Baseline146916202632
 246104135461, 19857P <0.0001P <0.0001Baseline1856917274835
 322140535550, 35581P <0.0001P <0.0001P = 0.9642186434158548
Scarring score (C)
 015519021207, 2996Baseline209515274835
 111449111, 1816P = 0.438Baseline2043411556
 29990192, 5111P = 0.927P = 0.941Baseline5897654651
 392475253, 24192P = 0.995P = 0.608P = 0.92370231749125
a

Scheffé correction used for multiple comparisons.

b

n = number of individuals with quantifiable C. trachomatis bacterial load.

Spatial structure of active trachoma and Chlamydia trachomatis infection

Significant positive spatial autocorrelation was evident for C. trachomatis infection (Moran's I = 0.19, P < 0.0001) but not active trachoma (Moran's I = 0.07, P = 0.0659). Semivariograms demonstrate that autocorrelation in infection is negligible in distances greater than 1719 m (Fig. 3). We found no evidence of spatial autocorrelation in the distribution of C. trachomatis load (Moran's I = 0.05, P = 0.4464).

Empirical semivariograms and fitted models for household prevalence of (a) ocular C. trachomatis infection, (b) active trachoma and the distribution of (c) ocular C. trachomatis bacterial load. (a) Unadjusted household prevalence of C. trachomatis infection. (b) Household prevalence of active trachoma in 1–9 year olds. (c) Ocular C. trachomatis bacterial load. Prevalence data were log transformed (ln(ln+1)) due to significant negative skew. Active trachoma is defined by TF/TI by the WHO Simplified Grading System (Thylefors et al. 1987) (F2/F3 or P3 by the Modified FPC Grading System; Dawson, Jones and Tarizzo 1981). Distance is indicated in metres. Model fit with the smallest residual sum of squares (Matern, M. Stein's Parameterization (Ste)). All values of Kappa (smoothing parameter of the Matern model) tested. Nugget, sill, range and Kappa are all estimated from the data.
Figure 3.

Empirical semivariograms and fitted models for household prevalence of (a) ocular C. trachomatis infection, (b) active trachoma and the distribution of (c) ocular C. trachomatis bacterial load. (a) Unadjusted household prevalence of C. trachomatis infection. (b) Household prevalence of active trachoma in 1–9 year olds. (c) Ocular C. trachomatis bacterial load. Prevalence data were log transformed (ln(ln+1)) due to significant negative skew. Active trachoma is defined by TF/TI by the WHO Simplified Grading System (Thylefors et al. 1987) (F2/F3 or P3 by the Modified FPC Grading System; Dawson, Jones and Tarizzo 1981). Distance is indicated in metres. Model fit with the smallest residual sum of squares (Matern, M. Stein's Parameterization (Ste)). All values of Kappa (smoothing parameter of the Matern model) tested. Nugget, sill, range and Kappa are all estimated from the data.

Chlamydia trachomatis load was the strongest predictor of clinically active trachoma. In accordance with the semivariograms, including spatial structure in multivariable mixed effects regression analyses for active trachoma and C. trachomatis infection improves the fit of the models (Table 2).

Table 2.

Multivariable mixed effects logistic regression analysis showing the effect of spatial dependence on clinically active trachoma and ocular C. trachomatis infection.

ModelPredictor variablesnAICa
C. trachomatis infection
 No spatialbAge1426854.8
 Spatialc801.8
 No spatialAge1426546.4
 SpatialActive trachomad163495.6
Active trachoma
 No spatialAge1426697.9
 Spatial659.0
 No spatialAge1426389.5
 SpatialC. trachomatis infection224362.3
 No spatialAge1426251.2
 SpatialC. trachomatis loade180232.7
ModelPredictor variablesnAICa
C. trachomatis infection
 No spatialbAge1426854.8
 Spatialc801.8
 No spatialAge1426546.4
 SpatialActive trachomad163495.6
Active trachoma
 No spatialAge1426697.9
 Spatial659.0
 No spatialAge1426389.5
 SpatialC. trachomatis infection224362.3
 No spatialAge1426251.2
 SpatialC. trachomatis loade180232.7
a

AIC = Akaike information criterion.

b

With household or village as cluster variables.

c

Including of spatial structure.

d

Defined as TF/TI using the WHO simplified grading system (Thylefors et al. 1987).

e

Defined as log-(e) omcB copies/swab.

Table 2.

Multivariable mixed effects logistic regression analysis showing the effect of spatial dependence on clinically active trachoma and ocular C. trachomatis infection.

ModelPredictor variablesnAICa
C. trachomatis infection
 No spatialbAge1426854.8
 Spatialc801.8
 No spatialAge1426546.4
 SpatialActive trachomad163495.6
Active trachoma
 No spatialAge1426697.9
 Spatial659.0
 No spatialAge1426389.5
 SpatialC. trachomatis infection224362.3
 No spatialAge1426251.2
 SpatialC. trachomatis loade180232.7
ModelPredictor variablesnAICa
C. trachomatis infection
 No spatialbAge1426854.8
 Spatialc801.8
 No spatialAge1426546.4
 SpatialActive trachomad163495.6
Active trachoma
 No spatialAge1426697.9
 Spatial659.0
 No spatialAge1426389.5
 SpatialC. trachomatis infection224362.3
 No spatialAge1426251.2
 SpatialC. trachomatis loade180232.7
a

AIC = Akaike information criterion.

b

With household or village as cluster variables.

c

Including of spatial structure.

d

Defined as TF/TI using the WHO simplified grading system (Thylefors et al. 1987).

e

Defined as log-(e) omcB copies/swab.

Inflammatory and follicle scores were strongly associated with bacterial load. Inclusion of the spatial structure in models predicting C. trachomatis load improved the fit, but the effect of spatial dependence becomes undetectable when age and disease severity scores are included, thus resolving residual spatial variation (Table 3).

Table 3.

Multivariable mixed effects linear regression analysis of factors predictive of C. trachomatis load (omcB copies/swab) in infected individuals.

ModelVariablenORa95% CIP-ValueAICbBICcloglikd
Nulle
884.8894.3–439.4
Clustering
 Householdf884.3893.8–439.1
 Villagef882.1892.0–438.2
 Spatialg799.7834.8–388.8
Finalh
Including age and disease severity
 Spatial802.6844.1–388.3
 No spatial797.7829.6–388.8
 Age0–5 years872.600.99, 6.870.052
6–10 years450.700.24, 2.050.509
11–15 years151.770.43, 7.200.427
>15 years371.00
Disease severityInflammatory grade (P)
0461.00
1707.543.12, 18.20<0.0001
24622.88.15, 63.9<0.0001
32230.99.39, 101.50<0.0001
Follicular grade (F)
0911.00
1201.290.43, 3.840.649
2272.200.82, 5.880.114
3467.783.16, 19.15<0.0001
ModelVariablenORa95% CIP-ValueAICbBICcloglikd
Nulle
884.8894.3–439.4
Clustering
 Householdf884.3893.8–439.1
 Villagef882.1892.0–438.2
 Spatialg799.7834.8–388.8
Finalh
Including age and disease severity
 Spatial802.6844.1–388.3
 No spatial797.7829.6–388.8
 Age0–5 years872.600.99, 6.870.052
6–10 years450.700.24, 2.050.509
11–15 years151.770.43, 7.200.427
>15 years371.00
Disease severityInflammatory grade (P)
0461.00
1707.543.12, 18.20<0.0001
24622.88.15, 63.9<0.0001
32230.99.39, 101.50<0.0001
Follicular grade (F)
0911.00
1201.290.43, 3.840.649
2272.200.82, 5.880.114
3467.783.16, 19.15<0.0001

Chlamydia trachomatis load is defined as log-(e) omcB copies/swab. There was no evidence of heteroscedasticity of residuals (Breusch-Pagan/Cook Weisberg test for heteroscedasticity in the final model (χ2 = 0.44, P = 0.5079)).

a

Exponentiated coefficient.

b

AIC = Akaike information criterion.

c

BIC = Bayesian information criterion.

d

loglik = Log likelihoood.

e

Null model with dummy cluster variable.

f

Including household or village as cluster variables on outcome.

g

Including spatial structure.

h

Final model including covariates with and without adjustment for spatial structure.

Table 3.

Multivariable mixed effects linear regression analysis of factors predictive of C. trachomatis load (omcB copies/swab) in infected individuals.

ModelVariablenORa95% CIP-ValueAICbBICcloglikd
Nulle
884.8894.3–439.4
Clustering
 Householdf884.3893.8–439.1
 Villagef882.1892.0–438.2
 Spatialg799.7834.8–388.8
Finalh
Including age and disease severity
 Spatial802.6844.1–388.3
 No spatial797.7829.6–388.8
 Age0–5 years872.600.99, 6.870.052
6–10 years450.700.24, 2.050.509
11–15 years151.770.43, 7.200.427
>15 years371.00
Disease severityInflammatory grade (P)
0461.00
1707.543.12, 18.20<0.0001
24622.88.15, 63.9<0.0001
32230.99.39, 101.50<0.0001
Follicular grade (F)
0911.00
1201.290.43, 3.840.649
2272.200.82, 5.880.114
3467.783.16, 19.15<0.0001
ModelVariablenORa95% CIP-ValueAICbBICcloglikd
Nulle
884.8894.3–439.4
Clustering
 Householdf884.3893.8–439.1
 Villagef882.1892.0–438.2
 Spatialg799.7834.8–388.8
Finalh
Including age and disease severity
 Spatial802.6844.1–388.3
 No spatial797.7829.6–388.8
 Age0–5 years872.600.99, 6.870.052
6–10 years450.700.24, 2.050.509
11–15 years151.770.43, 7.200.427
>15 years371.00
Disease severityInflammatory grade (P)
0461.00
1707.543.12, 18.20<0.0001
24622.88.15, 63.9<0.0001
32230.99.39, 101.50<0.0001
Follicular grade (F)
0911.00
1201.290.43, 3.840.649
2272.200.82, 5.880.114
3467.783.16, 19.15<0.0001

Chlamydia trachomatis load is defined as log-(e) omcB copies/swab. There was no evidence of heteroscedasticity of residuals (Breusch-Pagan/Cook Weisberg test for heteroscedasticity in the final model (χ2 = 0.44, P = 0.5079)).

a

Exponentiated coefficient.

b

AIC = Akaike information criterion.

c

BIC = Bayesian information criterion.

d

loglik = Log likelihoood.

e

Null model with dummy cluster variable.

f

Including household or village as cluster variables on outcome.

g

Including spatial structure.

h

Final model including covariates with and without adjustment for spatial structure.

Cluster and outlier analysis of Chlamydia trachomatis infection

High load infections were clustered with other high load infections (HH clusters) (Fig. 4). Outliers where there was a single low load infection amidst predominantly high load infections (HL) were also demonstrated. There was no clustering of low load infections (or zero values from uninfected individuals) (LL clusters), and there were no statistically significant outlying high loads surrounded by predominantly low loads (LH). Analyses were conducted on the whole data set and infections only as described above. There were no individuals with infections below 10 000 omcB copies/swab noted within an HH cluster or as an HL outlier.

Clusters and outliers of high load ocular C. trachomatis infections. Chlamydia trachomatis load log transformed (ln(ln+1)) due to significant negative skew. Statistically significant positive values for the Local Moran's I statistic indicate clustering with similarly high (H-H) or low (L-L) values. Negative values indicate that neighbouring observations have dissimilar values and that this observation is an outlier (H-L or L-H). H-H clusters and H-L outliers are observed. There are no L-L clusters. Observation values represent C. trachomatis load. Adjacency is defined by the zone of indifference.
Figure 4.

Clusters and outliers of high load ocular C. trachomatis infections. Chlamydia trachomatis load log transformed (ln(ln+1)) due to significant negative skew. Statistically significant positive values for the Local Moran's I statistic indicate clustering with similarly high (H-H) or low (L-L) values. Negative values indicate that neighbouring observations have dissimilar values and that this observation is an outlier (H-L or L-H). H-H clusters and H-L outliers are observed. There are no L-L clusters. Observation values represent C. trachomatis load. Adjacency is defined by the zone of indifference.

DISCUSSION

The majority of ocular Chlamydia trachomatis infections occur in children, who have the highest loads and most severe active trachoma. However, infection predominantly occurs at low bacterial loads in the population overall. Similar findings have been observed in other studies (Solomon et al. 2003; Burton et al. 2006; Faal et al. 2006), though we found a greater prevalence of infection across all age groups typical of hyperendemic settings. Almost half the individuals with quantifiable infection had a normal clinical phenotype, though the mean C. trachomatis load was significantly lower than in those with active trachoma, which is consistent with other studies in meso and hyperendemic settings (Solomon et al. 2003; West et al. 2005).

In this population, C. trachomatis load increases with disease severity (for both follicular (F) and inflammatory (P) scores), the strongest association being with increasing P-scores. The association between ocular C. trachomatis load and disease severity in trachoma is supported by findings from other studies (Burton et al. 2003, 2006; Solomon et al. 2003; Michel et al. 2011). The association between C. trachomatis load and high F-scores is in part due to collinearity between F and P, where with high F-scores there is likely to be inflammation present. Inflammation has previously been found to be associated with high C. trachomatis loads and persistence of infection in children (Bobo et al. 1997). This is consistent with the high prevalence of infection and the spectrum of load and phenotype observed in this age group but may also be associated with pathogen virulence if there are different C. trachomatis strains in circulation. Further analysis is underway to investigate associations between pathogen genotype, clinical phenotype and geospatial clustering of strains.

There is spatial dependence in the distribution of C. trachomatis infection, demonstrated by positive spatial autocorrelation. The distance over which this occurs (1719 m) equates to that of village boundaries. We used this data-driven threshold in our geostatistical models to account for the difficulties in performing this type of analysis in small island populations.

Our data show that the highest burden of infection (and load) is in children under 10 years of age. There are usually only one or two children of this age group within a household in these communities (Last et al. 2014). The high load clusters (HH) and high load outliers (HL) are geographically close to the non-significant clusters and both exist within the village boundaries in this study (<200 m apart). These data support the hypothesis that transmission occurs at village level in this population. Spread from an individual within an HH cluster to an individual in a non-significant cluster is also possible and requires further investigation in longitudinal and mathematical modelling studies.

Although household and village-level clustering is evident in active trachoma and ocular C. trachomatis infection (Bailey et al. 1989; Blake et al. 2009; Hagi et al. 2010; Last et al. 2014), the inclusion of this spatial structure in regression models for active trachoma and C. trachomatis infection further improves model fit and demonstrates underlying spatial processes in the relationship between infection and disease, such that cases of active trachoma may represent recent exposure to C. trachomatis infection. The effect of spatial dependence in infection is greater than in active trachoma, perhaps reflecting the complexity of the disease process, where host–pathogen interactions contribute.

There was no global spatial autocorrelation evident for C. trachomatis bacterial load, likely reflecting the stronger influence of underlying social and biological rather than spatial processes. However, we were able to use local indicators of spatial association to examine fine-scale spatial clustering to identify clustering of high load infections. Spatial clusters, independent of age and gender, of individual infections with high bacterial loads (HH) and high load outliers that cluster with other low loads (HL) exist. Furthermore, there was no evidence of clustering of low load infections (LL), suggesting that high load infections may be important in transmission of chlamydial infection. There appears to be a threshold of C. trachomatis load below which HH clustering (and being a HL outlier) does not occur. The same phenomena were observed in data including infected and uninfected individuals and data with infected individuals only suggesting that low load infection may represent a negligible risk of transmission. This supports the described Allee effect, which hypothesises that a reduction in chlamydial fitness due to reduced pathogen population size or density results in its disappearance from a population (Chidambaram et al. 2005).

There are a limited number of studies that have assessed the spatial distribution of trachoma (Polack et al. 2005; Clements et al. 2010; Smith et al. 2013) and ocular C. trachomatis infection (Broman et al. 2006; Yohannan et al. 2014). Broman et al. (2006) did not find clustering of active trachoma in children under the age of 10 years, but found clusters of households with high bacterial loads (defined as the household mean load) in treatment-naïve communities, supporting the findings in this study. Yohannan et al. (2014) examined binary household-level data using a K-function nearest neighbours analysis. The methodology for cluster detection in these studies was heterogeneous, and measures of spatial dependence were not included in these analyses.

This cross-sectional study is limited in the assumption of load and clinical disease severity as a steady state. There are few data addressing stability of C. trachomatis load and disease phenotype (Bobo et al. 1997). Bobo et al. (1997) conducted weekly surveys for 3 months in hyperendemic communities, finding that 62% of children had at least one infection during that time and of those 64% were persistently infected and had higher mean C. trachomatis loads and more severe disease than those who were sporadically infected. Additionally, host conjunctival immune response and duration of infection add complexity to the interaction between C. trachomatis infection and disease severity (Faal et al. 2006; Gambhir et al. 2009). Chlamydia trachomatis strain diversity may also be associated with bacterial load, the spectrum of disease severity and the clustering of high load infections within these communities.

The role and importance of HH clusters and HL outliers in C. trachomatis transmission is speculative, but their presence, and the absence of low load clusters (LL) and low load outliers (LH), suggests that C. trachomatis load may have a role in transmission, and that these clusters may represent a source for spread of ocular C. trachomatis infection. Studies in trachoma and C. trachomatis infection in mouse models have suggested that C. trachomatis load is associated with transmission (Pal et al. 1998; West et al. 2005). There is also some evidence from studies of urogenital C. trachomatis infection in humans that individuals with asymptomatic infection have lower C. trachomatis loads than individuals with symptomatic infections (Wiggins et al. 2009) and that the chance of sexual transmission of C. trachomatis per sexual act may be influenced by load (Dirks et al. 2015). However, the determinants of C. trachomatis load and its role in transmission and the development of sequelae are not well understood (Vodstrcil et al. 2014). Further longitudinal data in the context of trachoma endemicity and mass drug treatment are required to fully address these questions and investigate the dynamics of C. trachomatis load in transmission.

CONCLUSION

This is the first study to use individual-level quantifiable Chlamydia trachomatis infections from a geospatially representative population-based sample to investigate spatial clustering of C. trachomatis infection. These data show that increasing C. trachomatis load is related to increasing disease severity in active trachoma, particularly with respect to inflammation. We have provided a global statistical measure for spatial autocorrelation in infection and disease and used local indicators of spatial association to describe the location and nature of the clusters in relation to C. trachomatis load.

These data suggest that high load C. trachomatis infections cluster spatially and may be important in transmission, although further longitudinal study is required. Further epidemiological and in vitro studies are required to provide a more complete picture of the relationship between disease severity and chlamydial load.

These geospatial tools may be useful as tools in trachoma surveillance to identify clusters of infection and thresholds of C. trachomatis bacterial load that may be important foci of transmission. Using these methods in conjunction with novel molecular tools to better define C. trachomatis strains and ‘virulence’ may also improve our understanding of C. trachomatis pathogenesis and transmission.

Acknowledgments

The authors thank to colleagues in the Programa Nacional de Saúde de Visão in Bissau and to the communities of the Bijagós Archipelago, our field research team and all study participants in Guinea Bissau.

FUNDING

This work was supported by a Wellcome Trust Clinical Research Training Fellowship (grant number 097330/Z/11/Z).

REFERENCES

Alexander
ND
,
Solomon
AW
,
Holland
MJ
et al. .
An index of community ocular Chlamydia trachomatis load for control of trachoma
.
T R Soc Trop Med H
2005
;
99
:
175
7
.

Andreasen
AA
,
Burton
MJ
,
Holland
MJ
et al. .
Chlamydia trachomatis ompA variants in trachoma: what do they tell us?
PLoS Neglect Trop D
2008
;
2
:
e306
.

Anselin
L
.
Local indicators of spatial Association: LISA
.
Geogr Anal
1995
;
27
:
93
115
.

Bailey
R
,
Osmond
C
,
Mabey
DC
et al. .
Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure
.
Int J Epiemiol
1989
;
18
:
944
51
.

Baker
MC
,
Mathieu
E
,
Fleming
FM
et al. .
Mapping, monitoring and surveillance of neglected tropical diseases: towards a framework
.
Lancet
2010
;
375
:
231
8
.

Bivand
R
.
Spdep: Spatial Dependence: Weighting Schemes, Statistics and Models
.
R Package Version 0.5-4
.
2010
; http://CRAN.Rproject.org/package=spdep
(6 May 2017, date last accessed)
.

Blake
IM
,
Burton
MJ
,
Bailey
RL
et al. .
Estimating household and community transmission of ocular Chlamydia trachomatis
.
PLoS Neglect Trop D
2009
;
3
:
e401
.

Bobo
LD
,
Novak
M
,
Munoz
B
et al. .
Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection
.
J Infect Dis
1997
;
176
:
1524
30
.

Broman
AT
,
Shum
K
,
Munoz
B
et al. .
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania
.
Invest Ophth Vis Sci
2006
;
47
:
99
104
.

Burton
MJ
,
Holland
MJ
,
Faal
N
et al. .
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages
.
Invest Ophth Vis Sci
2003
;
10
:
4215
22
.

Burton
MJ
,
Holland
MJ
,
Jeffries
D
et al. .
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop?
Clin Infect Dis
2006
;
42
:
463
70
.

Chang
K
.
An Introduction to Geographic Information Systems
,
5th edn
.
New York
:
Thomas D. Timp
2010
,
327
40
.

Chidambaram
JD
,
Lee
DC
,
Porco
TC
et al. .
Mass antibiotics for trachoma and the Allee effect
.
Lancet Infect Dis
2005
;
5
:
194
6
.

Clements
AC
,
Kur
LW
,
Gatpan
G
et al. .
Targeting trachoma control through risk mapping: the example of Southern Sudan
.
PLoS Neglect Trop D
2010
;
4
:
e799
.

Cliff
AD
,
Ord
JK
.
Spatial Processes
.
London
:
Pion
,
1981
,
63
5
.

Dawson
CR
,
Jones
BR
,
Tarizzo
ML
.
Guide to Trachoma Control in Programs for the Prevention of Blindness
.
Geneva
:
World Health Organization
.
1981
.

Diggle
PJ
,
Tawn
JA
,
Moyeed
RA
.
Model-based geostatistics. Royal Statistics Society
.
Appl Stat
1998
;
47
:
299
350
.

Dirks
JAMC
,
Wolffs
PFG
,
Dukers-Muijrers
NHTM
et al. .
Chlamydia trachomatis load in population-based screening and STI clinics: Implications for screening policy
.
PLoS One
2015
;
10
:
e0121433
.

Edwards
T
,
Harding-Esch
EM
,
Hailu
G
et al. .
Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin
.
Trop Med Int Health
2008
;
13
:
556
65
.

Faal
N
,
Bailey
RL
,
Jeffries
D
et al. .
Conjunctival FOXP3 expression in trachoma: Do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?
PLoS Med
2006
;
3
:
e266
.

Gambhir
M
,
Basanez
MG
,
Burton
MJ
et al. .
The development of an age structured model for trachoma transmission dynamics, pathogenesis and control
.
PLoS Neglecy Trop D
2009
;
3
:
e46
.

Hagi
M
,
Schemann
JF
,
Mauny
F
et al. .
Active trachoma among children in Mali: clustering and environmental risk factors
.
PLoS Neglect Trop D
2010
;
4
:
e583
.

Harding-Esch
E
,
Edwards
T
,
Mkocha
H
et al. .
Trachoma prevalence and associated risk factors in the gambia and tanzania: baseline results of a cluster randomized controlled trial
.
PLoS Neglect Trop D
2010
;
4
:
e861
.

Hiemstra
PH
,
Pebesma
EJ
,
Twenhofel
CJW
et al. .
Real-time automatic interpolation of ambient gamma dose rates from the dutch radioactivity monitoring network
.
Comput Geosci
2009
;
35
:
1711
21
.

Jalal
H
,
Verlander
NQ
,
Kumar
N
et al. .
Genital chlamydial infection: association between clinical features, organism genotype and load
.
J Med Microbiol
2011
;
60
:
881
8
.

Keenan
JD
,
Lakew
T
,
Alemayehu
W
et al. .
Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
.
Am J Trop Med Hyg
2010
;
82
:
482
7
.

Kuper
H
,
Solomon
AW
,
Buchan
J
et al. .
A critical review of the SAFE strategy for the prevention of blinding trachoma
.
Lancet Infect Dis
2003
;
3
:
372
81
.

Last
A
,
Roberts
CH
,
Cassama
E
et al. .
Plasmid copy number and disease severity in naturally occurring ocular Chlamydia trachomatis infection
.
J Clin Microbiol
2014a
;
52
:
324
7
.

Last
AR
,
Burr
SE
,
Weiss
HA
et al. .
Risk factors for active trachoma and ocular Chlamydia trachomatis Infection in Treatment-naïve Trachoma-hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
.
PLoS Neglect Trop D
2014b
;
8
:
e2900
.

Michel
CE
,
Roper
G
,
Devina
MA
et al. .
Correlation of clinical trachoma and infection in Aboriginal communities
.
PLoS Neglect Trop D
2011
;
5
:
e986
.

Moran
PA
.
Notes on continuous stochastic phenomena
.
Biometrika
1950
;
37
:
17
23
.

Pal
S
,
Hui
W
,
Peterson
EM
et al. .
Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection
.
J Med Microbiol
1998
;
47
:
599
605
.

Pinheiro
J
,
Bates
D
,
DebRoy
S
et al. .
nlme: Linear and Nonlinear Mixed Effects Models
.
R package version 3
.
2014
,
1
117
http://CRAN.R-project.org/package=nlme
(6 May 2017, date last accessed)
.

Polack
SR
,
Solomon
AW
,
Alexander
NDE
et al. .
The household distribution of trachoma in a Tanzanian village: an application of GIS to the study of trachoma
.
T Roy Soc Med Hyg
2005
;
99
:
218
25
.

Roberts
CH
,
Last
A
,
Molina-Gonzalez
S
et al. .
Development and evaluation of a next generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections
.
J Clin Microbiol
2013
;
51
:
2195
203
.

Ruxton
GD
,
Beauchamp
G
.
Time for some a priori thinking about post hoc testing
.
Behav Ecol
2008
;
19
:
690
3
.

Smith
JL
,
Flueckiger
RL
,
Hooper
PJ
et al. .
The geographical distribution and burden of trachoma in Africa
.
PLoS Neglect Trop D
2013a
;
7
:
e2359
.

Smith
JL
,
Haddad
D
,
Polack
S
et al. .
Mapping the global distribution of trachoma: why an updated atlas is needed
.
PLoS Neglect Trop D
2011
;
5
:
e973
.

Smith
JL
,
Sturrock
HJ
,
Olives
C
et al. .
Comparing the performance of cluster random sampling and integrated threshold mapping for targeting trachoma control, using computer simulation
.
PLoS Neglect Trop D
2013b
;
7
:
e2389
.

Solomon
AW
,
Holland
MJ
,
Alexander
ND
et al. .
Mass treatment with single-dose azithromycin for trachoma
.
N Engl J Med
2004
;
351
:
1962
71
.

Solomon
AW
,
Holland
MJ
,
Burton
MJ
et al. .
Strategies for control of trachoma: observational study with quantitative PCR
.
Lancet
2003
;
362
:
198
204
.

Stare
D
,
Harding-Esch
E
,
Munoz
B
et al. .
Design and baseline data of a randomised trial to evaluate coverage and frequency of mass treatment with azithromycin: The Partnership for the Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia
.
Ophthalmic Epidemiol
2011
;
18
:
20
9
.

Thylefors
B
,
Dawson
CR
,
Jones
BR
et al. .
A simple system for the assessment of trachoma and its complicatios
.
Bull World Health Organ
1987
;
65
:
477
83
.

Van der Linde
HA
,
Dankin
MH
.
Enhancing sustainability: resources for our future. SUI technical series
Vol. 1
.
Proceedings of a Workshop Held at the World Conservation Congress for the Sustainable Use Initiative (SUI
).
IUCN, The World Conservation Union
,
Montreal Canada
.
1998
.

Vodstrcil
LA
,
McIver
R
,
Huston
WM
et al. .
The epidemiology of organism load in genital Chlamydia trachomatis infection—a systematic review
.
J Infect Dis
2014
;
211
:
1628
45
.

West
ES
,
Munoz
B
,
Mkocha
H
et al. .
Mass treatment and the effect of the load in Chlamydia trachomatis infection in a trachoma-hyperendemic community
.
Invest Ophth Vis Sci
2005
;
46
:
83
7
.

West
SK
,
Moncada
J
,
Munoz
B
et al. .
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
J Infect Dis
2014
;
210
:
65
71
.

Wiggins
R
,
Graf
S
,
Low
N
et al. (Group CSSS).
Real-time quantitative PCR to determine Chlamydial load in men and women in a community setting
.
J Clin Microbiol
2009
;
47
:
1824
9
.

World Bank
.
From the Climatic Research unit (CRU) at the University of East Anglia (UEA)
.
Climate Change Knowledge Portal
:
Guinea Bissau
.
2013
. .

Yohannan
J
,
He
B
,
Wang
J
et al. .
Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment
.
Int Ophth Vis Sci
2014
;
55
:
4144
50
.

Zucchini
W
.
An introduction to model selection
.
J Math Psychol
2000
;
44
:
41
61
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.